{'fraction_non_alphanumeric': 0.025465230166503428, 'fraction_numerical': 0.0, 'mean_word_length': 6.3, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Bilateral anterior uveitis after intense pulsed light therapy for pigmented eyelid lesions.

Over the past decade, the application of photochemorejuvenation in the areas of dermatology and cosmetic surgery has soared in popularity, with a purported threefold increase in the number of laser-based procedures performed over this period. As a noninvasive, nonablative procedure involving little ‘‘downtime’’ and with well-documented improvements in skin conditions such as telangiectasia, dyspigmentation, coarsened skin texture, and wrinkling, the success of photochemorejuvenation techniques has been mostly guaranteed. Currently, ease of accessibility, with many procedures now being performed by nonmedically trained individuals in beauty therapy salons around the world, has further impelled its popularity. Intense pulsed light (IPL) therapy is one such modality favored for its global photorejuvenative qualities, addressing dyspigmentation, improving skin texture, and minimizing overall redness and telangiectasia.